About Ketorolac Tromethamine API
Therapeutic CategoryTratamiento del dolor

CAS Number
74103-07-4
API Technology
Synthetic
Dose Form
Nasal
Dr Reddy's Development Status
Available
Available Regulatory Filing
China DMF, USDMF, CEP Submitted, Brazil DMF, Korea DMF, Russia DMF
Mechanism of Action
Ketorolac has analgesic, anti-inflammatory, and antipyretic properties.
The mechanism of action of SPRIX, like that of other NSAIDs, is not completely understood but involves inhibition of cyclooxygenase (COX-1 and COX-2), an early component of the arachidonic acid cascade, resulting in the reduced synthesis of prostaglandins, thromboxanes, and prostacyclin.
Ketorolac is a potent inhibitor of prostaglandin synthesis in vitro. Ketorolac concentrations reached during therapy have produced in vivo effects. Prostaglandins sensitize afferent nerves and potentiate the action of bradykinin in inducing pain in animal models. Prostaglandins are mediators of inflammation. Because ketorolac is an inhibitor of prostaglandin synthesis, its mode of action may be due to a decrease of prostaglandins in peripheral tissues.
Indication
SPRIX is a nonsteroidal anti-inflammatory drug indicated in adult patients for the short term (up to 5 days) management of moderate to moderately severe pain that requires analgesia at the opioid level.
Related APIs
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
FAQs
Blood pressure (BP) should be monitored closely during the initiation of NSAID treatment and throughout the course of therapy.
50 kg or more: 31.5 mg every 6 to 8 hours; less than 50 kg: 15.75 mg (1 spray in each nostril). 15 or 30 mg, injected into a muscle or a vein four times a day.
To relieve moderately severe pain, usually after surgery.
It belongs to the group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs).
We offer Crystalline form
Meet with our product experts in one-on-one virtual sessions at https://api.drreddys.com/meet-api-experts or Write to us at [email protected].
Descargo de responsabilidad
Ninguna información en este sitio web, incluyendo cualquier referencia a cualquier producto o servicio, constituye una oferta de venta ni se interpretará como tal. Los productos protegidos por patentes válidas no se ofrecen ni suministran para uso comercial. Sin embargo, en ciertos casos, a discreción exclusiva de Dr. Reddy's y sujeto a los requisitos legales locales, las cantidades de investigación de dichos productos pueden ofrecerse para fines de presentaciones regulatorias según la Sección 107A de la Ley de Patentes de la India (exención de Bolar), donde existan dichas exenciones regulatorias. Los compradores deben realizar su propia evaluación del producto o servicio, incluyendo el escenario de patentes en sus respectivos mercados, y serán responsables de todas las responsabilidades relacionadas con las patentes. Dr. Reddy's renuncia a todas las garantías, expresas o implícitas, incluyendo, entre otras, las garantías de comerciabilidad, idoneidad para un propósito particular y no infracción.